Eradication of hospital-acquired venous thromboembolism

Samuel Z. Goldhaber

doi:10.1160/TH10-05-0267

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2010; 104(06): 1089-1092
DOI: 10.1160/TH10-05-0267

Clinical Focus

Schattauer GmbH

Eradication of hospital-acquired venous thromboembolism

Samuel Z. Goldhaber

¹Venous Thromboembolism Research Group, Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA

› Author Affiliations

Abstract

Full Text

References

References
1 Goldhaber SZ. Venous thromboembolism risk among hospitalized patients: magnitude of the risk is staggering. Am J Hematol 2007; 82: 775-776.
2 Anderson Jr FA, Zayaruzny M, Heit JA, Fidan D, Cohen AT. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 2007; 82: 777-782.
3 Galson SK. The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. (accessed online April 29, 2010 at http://www.surgeongeneral.gov/topics/deepvein ).
4 Piazza G, Goldhaber SZ. Improving clinical effectiveness in thromboprophylaxis for hospitalized medical patients. Am J Med 2009; 122: 230-232.
5 Goldhaber SZ, Rosenbaum E. The Surgeon General’s call to action exemplifies the role of advocacy in preventing venous thromboembolism. Am J Med 2009; 122: 791-792.
6 Streiff MB, Haut ER. The CMS ruling on venous thromboembolism after total knee or hip arthroplasty: weighing risks and benefits. J Am Med Assoc 2009; 301: 1063-1065.
7 Pronovost PJ, Goeschel CA, Wachter RM. The wisdom and justice of not paying for “preventable complications”. . J Am Med Assoc 2008; 299: 2197-2199.
8 Amin A, Stemkowski S, Lin J, Yang G. Thromboprophylaxis rates in US medical centers: success or failure?. J Thromb Haemost 2007; 5: 1610-1616.
9 Piazza G, Seddighzadeh A, Goldhaber SZ. Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent. Chest 2007; 132: 554-561.
10 Kahn SR, Panju A, Geerts W. et al. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res 2007; 119: 145-155.
11 Kucher N, Spirk D, Kalka C. et al. Clinical predictors of prophylaxis use prior to the onset of acute venous thromboembolism in hospitalized patients SWIss Venous ThromboEmbolism Registry (SWIVTER). J Thromb Haemost 2008; 6: 2082-2087.
12 Gussoni G, Campanini M, Silingardi M. et al. Inhospital symptomatic venous thromboembolism and antithrombotic prophylaxis in Internal Medicine. Findings from a multicenter, prospective study. Thromb Haemost 2009; 101: 893-901.
13 Tapson VF, Decousus H, Pini M. et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 2007; 132: 936-945.
14 Cohen AT, Tapson VF, Bergmann JF. et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008; 371: 387-394.
15 Dentali F, Douketis JD, Gianni M. et al. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 2007; 146: 278-288.
16 Wein L, Wein S, Haas SJ. et al. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167: 1476-1486.
17 Deitelzweig SB, Becker R, Lin J. et al. Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism. Thromb Haemost 2008; 100: 810-820.
18 Eikelboom JW, Quinlan DJ, O’Donnell M. Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials. Circulation 2009; 120: 2006-2011.
19 Glynn RJ, Ridker PM, Goldhaber SZ. et al. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women’s Health Study. Circulation 2007; 116: 1497-1503.
20 Glynn RJ, Danielson E, Fonseca FA. et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 2009; 360: 1851-1861.
21 Urbankova J, Quiroz R, Kucher N. et al. Intermittent pneumatic compression and deep vein thrombosis prevention. A meta-analysis in postoperative patients. Thromb Haemost 2005; 94: 1181-1185.
22 Nicolaides A, Goldhaber SZ, Maxwell GL. et al. Cost benefit of intermittent pneumatic compression for venous thromboembolism prophylaxis in general surgery. Int Angiol 2008; 27: 500-506.
23 Turpie AG, Bauer KA, Caprini JA. et al. Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost 2007; 5: 1854-1861.
24 Dennis M, Sandercock PA, Reid J. et al. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet 2009; 373: 1958-1965.
25 Spencer FA, Lessard D, Emery C. et al. Venous thromboembolism in the outpatient setting. Arch Intern Med 2007; 167: 1471-1475.
26 Sweetland S, Green J, Liu B. et al. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. Br Med J 2009; 339: b4583.
27 Arcelus JI, Monreal M, Caprini JA. et al. Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry. Thromb Haemost 2008; 99: 546-551.
28 Piazza G, Goldhaber SZ. Computerized decision support for the cardiovascular clinician: applications for venous thromboembolism prevention and beyond. Circulation 2009; 120: 1133-1137.
29 van Wyk JT, van Wijk MA, Sturkenboom MC. et al. Electronic alerts versus on-demand decision support to improve dyslipidemia treatment: a cluster randomized controlled trial. Circulation 2008; 117: 371-378.
30 Jha AK, DesRoches CM, Campbell EG. et al. Use of electronic health records in U.S. hospitals. N Engl J Med 2009; 360: 1628-1638.
31 Amarasingham R, Plantinga L, Diener-West M. et al. Clinical information technologies and inpatient outcomes: a multiple hospital study. Arch Intern Med 2009; 169: 108-114.
32 D’Avolio LW. Electronic medical records at a crossroads: impetus for change or missed opportunity?. J Am Med Assoc 2009; 302: 1109-1111.
33 Kucher N, Koo S, Quiroz R. et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005; 352: 969-977.
34 Baroletti S, Munz K, Sonis J. et al. Electronic alerts for hospitalized high-VTE risk patients not receiving prophylaxis: a cohort study. J Thromb Thrombolysis 2008; 25: 146-150.
35 Fiumara K, Piovella C, Hurwitz S. et al. Multi-screen electronic alerts to augment venous thromboembolism prophylaxis. Thromb Haemost 2010; 103: 312-317.
36 Halpern SD, Ubel PA, Asch DA. Harnessing the power of default options to improve health care. N Engl J Med 2007; 357: 1340-1344.
37 Lecumberri R, Marques M, Diaz-Navarlaz MT. et al. Maintained effectiveness of an electronic alert system to prevent venous thromboembolism among hospitalized patients. Thromb Haemost 2008; 100: 699-704.
38 Piazza G, Rosenbaum EJ, Pendergast W. et al. Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients. Circulation 2009; 119: 2196-2201.
39 Piazza G, Fanikos J, Zayaruzny M. et al. Venous thromboembolic events in hospitalised medical patients. Thromb Haemost 2009; 102: 505-510.
40 Fanikos J, Piazza G, Zayaruzny M. et al. Long-term complications of medical patients with hospital-acquired venous thromboembolism. Thromb Haemost 2009; 102: 688-693.